With a new management team in place and a focus on a market largely ignored by big pharmaceutical companies, a tiny biotech company started by two researchers from the University of Delaware is ramping up operations.
With a new management team in place and a focus on a market largely ignored by big pharmaceutical companies, a tiny biotech company started by two researchers from the University of Delaware is ramping up operations.
